AdAlta Ltd (ASX:1AD) CEO Dr Tim Oldham speaks with Proactive after announcing all healthy volunteers in its AD-214 Phase I extension study have successfully received three doses. The milestone allows pharmacokinetic and receptor engagement analysis to be ...

AdAlta making material progress on partnering talks

AdAlta Ltd (ASX:1AD) has reported positive outcomes from its AD-214 Phase 1 extension study. This study aims to assess the safety and availability of multiple 10 milligrams per kilogram intravenous doses of AD-214, the company's lead drug candidate.

AdAlta doses volunteers in Phase 1 extension study of AD-214, with promising safety results

AdAlta Ltd (ASX:1AD) has been selected for an extended oral presentation at the 11th Molecular Pharmacology of GPCRs meeting to be held in Melbourne from November 15-17, 2023.

AdAlta to present lead product AD-214 at MPGPCR 2023 pharmacology conference

Traders have been aggressively selling the three after Novo Nordisk appeared to have made a breakthrough in its wonder drug, Ozempic.

Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff

AdAlta Ltd (ASX:1AD) has received its FY2023 Research and Development Tax Incentive (RDTI) refund of $2,350,940 from the Australian Government. The clinical-stage drug discovery company received the refund for 43.

AdAlta receives $2.3 million FY23 R&D refund; extends loan repayment terms

AdAlta Ltd (ASX:1AD) has received its FY2023 Research and Development Tax Incentive (RDTI) refund of $2,350,940 from the Australian Government.

AdAlta Ltd (ASX:1AD) has received its FY2023 Research and Development Tax Incentive (RDTI) refund of $2,350,940 from the Australian Government. The clinical-stage drug discovery company received the refund for 43.5% of eligible expenditure. The Research ...

AdAlta Ltd (ASX:1AD) has received its FY2023 Research and Development Tax Incentive (RDTI) refund of $2,350,940 from the Australian Government. The clinical-stage drug discovery company received ...

AdAlta Ltd (ASX:1AD) CEO Dr Tim Oldham speaks with Proactive after receiving the results of dose simulation studies that support the potential efficacy of its i-body drug candidate AD-214 in ...

Adalta Says New AD-214 Dosing Models Enhance Partnering Potential

AdAlta

At HackerNoon, we pride ourselves on supporting startups because we know how hard it can be to start and run a company. 

What Are the Top Startups in Oceania?

Explore how in an ironic twist ELIZA's Lisp adaptation overshadowed its original intent as a research platform, leading to widespread misinterpretation.



The Accidental AI: How ELIZA's Lisp Adaptation Derailed Its Original Research Intent

Evgeniia Megrian shares her journey as a sales hunter in tech, overcoming challenges, and the importance of supportive networks in career growth.


The Importance of Persistence and Adaptability: Interview with Evgeniia Megrian, Sales Hunter

Headless Commerce & APIs - easy way to build a scalable eCommerce platform. 

APIs & Headless Commerce: Pioneering eCommerce Adaptability & Progress

Researchers present ChipNeMo, using domain adaptation to enhance LLMs for chip design, achieving up to 5x model size reduction with better performance.

ChipNeMo: Domain-Adapted LLMs for Chip Design: ChipNemo Domain Adaptation Methods

To get Large Language Models to work within your budged both in terms of compute and memory, LoRA is a fundamental quantisation algorithm.

What Is LoRA? The Low-Ranking Adaptation of LLMs Explained

Explore how K-SIF and SIF, based on signature theory, enhance anomaly detection in complex functional data.

How K-SIF and SIF Revolutionize Anomaly Detection in Complex Datasets

Learn how to choose the perfect 3D visualization studio by evaluating their portfolio, style, and technology to ensure they bring your vision to life.

ADALTA

adalta.com.au

employees

Since n.d.

COMPANY RANKING

ADALTA

EVERGREEN INDEX #2208

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #AdAlta

AdAlta WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

ADALTA

adalta.com.au

employees

Since n.d.

COMPANY RANKING

ADALTA

EVERGREEN INDEX #2208

RELATED COMPANIESRANK

HACKERNOON STORIES ON ADALTA

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #AdAlta

AdAlta WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!